Celltrion’s antibody for flu gets US patent

Published : Sept 9, 2016 - 15:36 Updated : Sept 9, 2016 - 15:36

◀ Back to List
More article by this Writer

[THE INVESTOR] Celltrion announced on Sept. 9 that CT-P23, its antibody to treat seasonal flu, has obtained a US patent.

This antibody neutralizes Influenza A virus and is effective in diagnosis, prevention and treatment of the virus, the biopharmaceutical company explained.

By Hwang You-mee (glamazon@heraldcorp.com)

◀ Back to List
More article by this Writer

LATEST NEWS

>

S. Korea not to attend Sado mine memorial: foreign ministry
>

[Weekender] Korea's traditional sauce culture gains global recognition
>

[What to Play] Cozy songs to warm you up
>

Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
>

Gyeongju blends old with new
>

At Gwangcheonok, try North Korean-style sundae gukbap
>

Over 80,000 malicious calls made to Seoul call center since 2020
>

Trump picks ex-N. Korea policy official as his principal deputy national security adviser
>

BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'
>

What you need to know about Adani's US bribery indictment